Video
Top ten take-home messages from the 2026 ACC/AHA multisociety dyslipidaemia guideline (Leslie Cho)
The headline points of the 2026 United States dyslipidaemia guideline. Included as context: no CETP inhibitor is recommended in it, and this is the framework any approval would land in.
Player and playback by Radcliffe Cardiology; the framing above is cetpinhibition.org's. Page updated 18 August 2026.